Congratulations! GenChem & GenPharm successfully Listed as Provincial-level Foreign-Funded R&D Center
作者： 点击：14 发布时间：2026-01-17
Recently, GenChem & GenPharm has been successfully included in the second batch of 2025 for the list of Foreign-Funded R&D Centers eligible for tax exemption and refund policies, which was jointly announced by Department of Commerce of Jiangsu Province, Department of Finance of Jiangsu Province, Nanjing Customs, and Jiangsu Provincial Tax Service, State Taxation Administration. This inclusion, based on the company's robust R&D innovation capabilities and deep technological expertise, signifies authoritative recognition at the provincial level for its achievements in building a high-level scientific research platform.
In 2010, the company established its foreign-funded R&D center, named the "Polypeptide and Derivatives API Engineering Technology Research Center", devoting to the research and development of polypeptide-based active pharmaceutical ingredients (APIs), their derivatives, and pharmaceutical intermediates. In the same year, the R&D center was accredited as the "Changzhou Engineering Technology Research Center for Polypeptide APIs" and the "Jiangsu Foreign-Funded R&D Institution." In 2014, collaborating with Nanjing Normal University and Changzhou University, the company co-founded the "Jiangsu Engineering Technology Research Center for Peptide-based Pharmaceutical APIs and Derivatives." In 2020, " Polypeptide and Derivatives API Engineering Technology Research Center" was recognized as Jiangsu Provincial Engineering Research Center. In 2023, the company founded the "Jiangsu Postdoctoral Innovation Practice Base." This initiative fosters collaborative innovation among universities, research institutes, and enterprises, builds an independent corporate innovation platform, deepens the integration of industry, academia, research, and application, and facilitates the efficient flow of talent and intellectual property between companies, universities, and research institutes.
Looking forward, GenChem & GenPharm will continue to strengthen exchanges and cooperation with high-level universities and research institutes. We will further refine our R&D innovation system and operational mechanisms, integrate the resources and talent advantages of both universities and companies, accelerate breakthroughs in key core technologies, enhance the efficiency of transforming scientific and technological achievements, and continuously consolidate and strengthen the company's core competitiveness.
